To subscribe with us, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

The Asia Pacific region is expected to show the fastest growth in coming years. As the major investments by key market players in india and china are propelling the growth of the market in following region.

The two largest end user segments are pharmaceutical and biotechnology. They both together account for 43.8% share of the 3D cell culture market.

3D cell culture is a technique used in cell biology to grow and study cells in a three-dimensional environment that more closely mimics the natural environment of cells in living organisms. This method involves growing cells on a scaffold or in a hydrogel matrix that provides structural support and allows for the formation of complex cell-to-cell interactions. 3D cell culture has become increasingly popular in drug discovery and tissue engineering due to its ability to better predict how cells will behave in vivo.

There are several examples of 3D cell culture techniques, such as spheroids, organoids, and tissue engineering. Spheroids are spherical clusters of cells that can be used to study tumor growth and drug response. Organoids are 3D structures that mimic the structure and function of organs, such as the liver and intestine. Tissue engineering involves growing cells on a scaffold to create functional tissues, such as skin and bone, for transplantation.

3D cell cultures can be made using various methods, such as scaffold-based and scaffold-free techniques. Scaffold-based methods involve growing cells on a 3D scaffold made of natural or synthetic materials, such as hydrogels or extracellular matrices. Scaffold-free methods, such as hanging drop and magnetic levitation, do not require a scaffold and instead rely on the self-assembly of cells to form 3D structures. The choice of method depends on the specific application and the type of cells being cultured.

3D cell culture tissue models are complex 3D structures that mimic the structure and function of tissues in living organisms. These models are created by growing cells on a scaffold or in a hydrogel matrix that provides structural support and allows for the formation of complex cell-to-cell interactions. 3D tissue models have become increasingly popular in drug discovery and toxicity testing due to their ability to better predict how drugs and chemicals will behave in vivo. 

Global 3D Cell Culture Market size was valued at USD 1.12 billion in 2021 and is poised to grow from USD 1.3 billion in 2022 to USD 4.77 billion by 2030, growing at a CAGR of 15.6% in the forecast period (2023-2030). 

  ' Thermo Fisher Scientific Inc. (US) ', ' Corning Incorporated (US) ', ' Merck KGaA (Germany) ', ' Lonza Group AG (Switzerland) ', ' Becton, Dickinson and Company (US) ', ' 3D Biotek LLC (US) ', ' InSphero AG (Switzerland) ', ' Synthecon Inc. (US) ', ' Tecan Trading AG (Switzerland) ', ' PromoCell GmbH (Germany) ', ' Greiner Bio-One International GmbH (Austria) ', ' Avantor, Inc. (US) ', ' Sartorius AG (Germany) ', ' Nano3D Biosciences, Inc. (US) ', ' MIMETAS B.V. (Netherlands) ', ' QGel SA (Switzerland) ', ' TissUse GmbH (Germany) ', ' SynVivo, Inc. (US) ', ' Emulate, Inc. (US) ', ' CN Bio Innovations Ltd. (UK) '

Growing focus on personalized medicine: There is an increasing focus on personalized medicine, which requires the development of patient-specific models for drug testing and disease modeling. 3D cell culture technology can be used to create patient-specific models that can be used for personalized drug discovery and treatment. For instance, Hubrecht Organoid Technology (HUB) has developed a platform that uses patient-derived organoids for drug testing and personalized medicine.

 

Feedback From Our Clients

Global 3D Cell Culture Market

Product ID: SQMIG35G2036

$5,300
BUY NOW GET SAMPLE